DENVER, CO / ACCESSWIRE / January 11, 2016 / American Cannabis Company, Inc. (OTCQB: AMMJ) (the “Company”), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced the sale of over $50,000 of its proprietary product SoHum Living Soil(TM).
So-Hum Living Soil(TM) is a proprietary “just add water” growing medium that contains 100% bio-dynamic ingredients. Additionally, the blend contains all of the necessary nutrients required to grow a plant from start to finish, eliminating the need for nutrient mixing and reducing operator error.
Corey Hollister, president and CEO, American Cannabis Company, commented: “SoHum Living Soil(TM) is a key component of our complete cannabis cultivation solution. The ACC cultivation solution reduces risk and increases margin for clients by addressing nutrient feeding, watering, space utilization and lighting among other critical variables. As the medical marijuana markets mature and product testing is required, operators need confidence that they have a cultivation solution that will consistently deliver a clean, medicinal grade product to their patients. SoHum Living Soil(TM) was specifically developed to meet this need.”
About American Cannabis Company, Inc.:
American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. Through our two vertically integrated businesses, American Cannabis Consulting and American Cultivator Company, a group purchasing organization, we support our clients from concept to creation to commercialization to on-going operations.
For more information, please visit: www.americancannabiscompanyinc.com, www.sohumsoils.com
Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward- looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.